CSL faces shareholder class action involving CSL stock

Published on 10/22/2026 at 09:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CSL names Deborah Waterhouse CEO from February 1, 2027. CSL stock costs EUR 121.34 on October 22, 2026 at AUD 66.0 billion market value.

Legal and management milestones

CSL faced a shareholder class action on October 22, 2026, involving USD 5.0 billion in previously disclosed impairment charges.
Deborah Waterhouse is scheduled to become CEO on February 1, 2027, after her appointment on October 21, 2026.
CSL stock was trading at EUR 121.34 at 9:28 a.m. CEST at Lang & Schwarz on October 22, 2026.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (ISIN AU000000CSL8) faced a shareholder class action on October 22, 2026, over claims tied to its financial forecasts, while its stock was trading at EUR 121.34 at Lang & Schwarz. Reuters reported that CSL denied liability and planned to defend the proceeding.

What does the legal action involve?

The case concerns securities acquired between February 11, 2025, and May 11, 2026. Reuters said the claim relates to CSL's medium-term and fiscal 2026 guidance, including the May forecast of USD 15.2 billion in revenue on a constant-currency basis and a USD 5.0 billion impairment warning.

The legal dispute follows a difficult fiscal 2026. CSL reported a net loss after tax of USD 2.6 billion, while impairments reached USD 7.1 billion, according to Reuters.

Three events reshape CSL

On October 5, 2026, CSL agreed a collaboration with Alentis Therapeutics for lixudebart, including a USD 355 million upfront payment and up to USD 1.2 billion in additional commercial milestones, according to AFX News. On October 21, 2026, CSL named Deborah Waterhouse as its next CEO and managing director, effective February 1, 2027, as Reuters reported. The October 22, 2026 class action is the latest event, with the claim focused on guidance and disclosure matters.

Which dates matter next?

CSL's next scheduled corporate date is its annual general meeting on October 27, 2026, in Melbourne and online, according to CSL. The next reporting date shown for the company is February 10, 2027, for second-quarter fiscal 2027 results, as listed on the company profile accompanying the CEO report.

Stock price and investor perspective

CSL's market value stood at AUD 66.0 billion on October 22, 2026, while the latest reported fiscal 2026 loss and the shareholder case keep execution and disclosure central to the investment story. The scheduled leadership change adds a second near-term test as the company seeks to rebuild earnings after the USD 7.1 billion impairment charge.

CSL stock was trading at EUR 121.34 at Lang & Schwarz on October 22, 2026 at 9:28 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of CSL stock.